Compounds for inhibiting secretory leukocyte protease inhibitor (SLPI)
US11351144B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2018 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Dec 3, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds that are useful for inhibiting the secretion of secretory leukocyte protease inhibitor (SLPI) in a subject. Methods of inhibiting metastasis of cancer and methods of treating cancer in a subject are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.